Halfdanarson TR - Search Results

1

Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic Review.

Sonbol MB, Halfdanarson TR, Hilal T. Sonbol MB, et al. Among authors: halfdanarson tr. JAMA Oncol. 2020 Jul 1;6(7):1086-1092. doi: 10.1001/jamaoncol.2020.0078. JAMA Oncol. 2020. PMID: 32297906

2

Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors.

Naraev BG, Strosberg JR, Halfdanarson TR. Naraev BG, et al. Among authors: halfdanarson tr. Oncology. 2012;83(3):117-27. doi: 10.1159/000339539. Epub 2012 Jul 12. Oncology. 2012. PMID: 22797357 Free article. Review.

3

Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.

Halfdanarson TR, Strosberg JR. Halfdanarson TR, et al. Curr Clin Pharmacol. 2015;10(4):305-10. doi: 10.2174/1574884710666151020100211. Curr Clin Pharmacol. 2015. PMID: 26548907 Review.

4

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.

Sharma N, Naraev BG, Engelman EG, Zimmerman MB, Bushnell DL Jr, OʼDorisio TM, OʼDorisio MS, Menda Y, Müller-Brand J, Howe JR, Halfdanarson TR. Sharma N, et al. Among authors: halfdanarson tr. Pancreas. 2017 Feb;46(2):151-156. doi: 10.1097/MPA.0000000000000734. Pancreas. 2017. PMID: 27759712 Free PMC article.

5

Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.

Keutgen XM, Schadde E, Pommier RF, Halfdanarson TR, Howe JR, Kebebew E. Keutgen XM, et al. Among authors: halfdanarson tr. Semin Oncol. 2018 Aug;45(4):232-235. doi: 10.1053/j.seminoncol.2018.07.002. Epub 2018 Oct 11. Semin Oncol. 2018. PMID: 30318110 Review.

6

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Ramage J, Naraev BG, Halfdanarson TR. Ramage J, et al. Among authors: halfdanarson tr. Semin Oncol. 2018 Aug;45(4):236-248. doi: 10.1053/j.seminoncol.2018.08.004. Epub 2018 Oct 24. Semin Oncol. 2018. PMID: 30539715 Free article. Review.

7

Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.

Naraev BG, Ramirez RA, Kendi AT, Halfdanarson TR. Naraev BG, et al. Among authors: halfdanarson tr. Clin Lung Cancer. 2019 May;20(3):e376-e392. doi: 10.1016/j.cllc.2019.02.007. Epub 2019 Mar 1. Clin Lung Cancer. 2019. PMID: 30910575 Free article. Review.

8

Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X, Shen C, Duma N, Vera Aguilera J, Chintakuntlawar A, Price KA, Molina JR, Pagliaro LC, Halfdanarson TR, Grothey A, Markovic SN, Nowakowski GS, Ansell SM, Wang ML. Wang Y, et al. Among authors: halfdanarson tr. JAMA Oncol. 2019 Jul 1;5(7):1008-1019. doi: 10.1001/jamaoncol.2019.0393. JAMA Oncol. 2019. PMID: 31021376 Free PMC article.

9

Therapy With ¹⁷⁷Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors.

Kendi AT, Halfdanarson TR, Packard A, Dundar A, Subramaniam RM. Kendi AT, et al. Among authors: halfdanarson tr. AJR Am J Roentgenol. 2019 Aug;213(2):309-317. doi: 10.2214/AJR.19.21123. Epub 2019 Apr 30. AJR Am J Roentgenol. 2019. PMID: 31039017 Review.

10

The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.

Xie H, Liu J, Yadav S, Keutgen XM, Hobday TJ, Strosberg JR, Halfdanarson TR. Xie H, et al. Among authors: halfdanarson tr. Neuroendocrinology. 2020;110(3-4):234-245. doi: 10.1159/000501126. Epub 2019 May 24. Neuroendocrinology. 2020. PMID: 31121586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters